Cranial Suture Biology

Current Topics in Developmental Biology

Volumn 66, Issue , 2005, Pages 287-328

  Lenton, Kelly A ^a   Nacamuli, Randall P ^a   Wan, Derrick C ^a   Helms, Jill A ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH PROMOTOR; HOMEODOMAIN PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

ANIMAL; APOPTOSIS; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DURA MATER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PERIOSTEUM; PHYSIOLOGY; REVIEW; SKULL;

ANIMALS; APOPTOSIS; CRANIAL SUTURES; CRANIOSYNOSTOSES; DNA-BINDING PROTEINS; DURA MATER; GROWTH SUBSTANCES; HOMEODOMAIN PROTEINS; HUMANS; NUCLEAR PROTEINS; PERIOSTEUM; RECEPTORS, FIBROBLAST GROWTH FACTOR; SKULL; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR;

EID: 24644433908     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(05)66009-7     Document Type: Article

References (198)

1. Aalami O.O., Nacamuli R.P., Lenton K.A., Cowan C.M., Fang T.D., et al. Applications of a mouse model of calvarial healing: Differences in regenerative abilities of juveniles and adults. Plast. Reconstr. Surg. 114 (2004) 713-720
2. Agresti M., Schaefer R.B., Recinos R.F., and Gosain A.K. Detection of apoptosis in normal postnatal mouse cranial sutures (2003), Plastic Surgery Research Council, Las Vegas, NV
3. Anderson J., Burns H.D., Enriquez-Harris P., Wilkie A.O.M., and Heath J.K. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum. Mol. Genet. 7 (1998) 1475-1483
4. Antonopoulou I., Mavrogiannis L.A., Wilkie A.O., and Morriss-Kay G.M. Alx4 and Msx2 play phenotypically similar and additive roles in skull vault differentiation. J. Anat. 204 (2004) 487-499
5. Babler W.J., Persing J.A., Persson K.M., Winn H.R., Jane J.A., et al. Skull regrowth after coronal suterectomy, periostectomy, and dural transection. J. Neurosurg. 56 (1982) 529-535
6. Bellus G.A., Gaudenz K., Zackai E.H., Clarke L.A., Szabo J., et al. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat. Genet. 14 (1996) 174-176
7. Bialek P., Kern B., Yang X., Schrock M., Sosic D., et al. A twist code determines the onset of osteoblast differentiation. Dev. Cell 6 (2004) 423-435
8. Bouletreau P.J., Steinbrech D., Spector J.A., Warren S.M., Greenwald J.A., et al. Gene expression of transforming growth factor-beta 3 and tissue inhibitor of metalloproteinase type 1 during membranous bone healing in rats. J. Craniofac. Surg. 11 (2000) 521-526
9. Bourgeois P., Bolcato-Bellemin A.L., Danse J.M., Bloch-Zupan A., Yoshiba K., et al. The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum. Mol. Genet. 7 (1998) 945-957
10. Bradley J.P., Han V.K., Roth D.A., Levine J.P., McCarthy J.G., et al. Increased IGF-I and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion. Plast. Reconstr. Surg. 104 (1999) 129-138
11. Brunet L.J., McMahon J.A., McMahon A.P., and Harland R.M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280 (1998) 1455-1457
12. Butow K.W. Craniofacial growth disturbance after skull base and associated suture synostoses in the newborn chacma baboon: A preliminary report. Cleft Palate J. 27 (1990) 241-251
13. Canalis E., and Lian J.B. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9 (1988) 243-246
14. Canalis E., McCarthy T., and Centrella M. Isolation of growth factors from adult bovine bone. Calcif. Tissue Int. 43 (1988) 346-351
15. Carlton M.B., Colledge W.H., and Evans M.J. Crouzon-like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3{plus 45 degree rule}Fgf4 locus. Dev. Dyn. 212 (1998) 242-249
16. Carver E.A., Oram K.F., and Gridley T. Craniosynostosis in Twist heterozygous mice: A model for Saethre-Chotzen syndrome. Anat. Rec. 268 (2002) 90-92
17. Cassileth L.B., Bartlett S.P., Glat P.M., Gripp K.W., Muenke M., et al. Clinical characteristics of patients with unicoronal synostosis and mutations of fibroblast growth factor receptor 3: A preliminary report. Plast. Reconstr. Surg. 108 (2001) 1849-1854
18. Castanon I., and Baylies M.K. A Twist in fate: Evolutionary comparison of Twist structure and function. Gene 287 (2002) 11-22
19. Centrella M., and Canalis E. Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae. Proc. Natl. Acad. Sci. USA 82 (1985) 7335-7339
20. Centrella M., Horowitz M.C., Wozney J.M., and McCarthy T.L. Transforming growth factor-beta gene family members and bone. Endocr. Rev. 15 (1994) 27-39
21. Chai Y., Jiang X., Ito Y., Bringas Jr. P., Han J., et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 127 (2000) 1671-1679
22. Chellaiah A.T., McEwen D.G., Werner S., Xu J., and Ornitz D.M. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF{plus 45 degree rule}FGF-1. J. Biol. Chem. 269 (1994) 11620-11627
23. Chen L., Li D., Li C., Engel A., and Deng C.X. A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33 (2003) 169-178
24. Chen Z.F., and Behringer R.R. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9 (1995) 686-699
25. Christensen F.K., and Clark D.B. The effect of restricted suture growth on brain growth in dogs. Surg. Forum 21 (1970) 439-440
26. Chun K., Teebi A.S., Jung J.H., Kennedy S., Laframboise R., et al. Genetic analysis of patients with the Saethre-Chotzen phenotype. Am. J. Med. Genet. 110 (2002) 136-143
27. Cohen Jr. M.M. Transforming growth factor beta s and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis. J. Bone Miner. Res. 12 (1997) 322-331
28. Cohen Jr. M.M. Transforming growth factor betas and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis. J. Bone Miner. Res. 12 (1997) 322-331
29. Contractor A., Rogers C., Maron C., Henkemeyer M., Swanson G.T., et al. Trans-synaptic Eph receptor-ephrin signaling in hippocampal mossy fiber LTP. Science 296 (2002) 1864-1869
30. Couly G.F., Coltey P.M., and Le Douarin N.M. The triple origin of skull in higher vertebrates: A study in quail-chick chimeras. Development 117 (1993) 409-429
31. Cowan C.A., Yokoyama N., Bianchi L.M., Henkemeyer M., and Fritzsch B. EphB2 guides axons at the midline and is necessary for normal vestibular function. Neuron 26 (2000) 417-430
32. Crouzon O. Dysostose cranio-faciale héréditaire. Bull. Mem. Soc. Med. Hop. Paris 33 (1912) 545-555
33. Daluiski A., Engstrand T., Bahamonde M.E., Gamer L.W., Agius E., et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat. Genet. 27 (2001) 84-88
34. Dry G.M., Yasinskaya Y.I., Williams J.K., Ehrlich G.D., Preston R.A., et al. Inhibition of apoptosis: A potential mechanism for syndromic craniosynostosis. Plast. Reconstr. Surg. 107 (2001) 425-432
35. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2{plus 45 degree rule}Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
36. Duprez D., Bell E.J., Richardson M.K., Archer C.W., Wolpert L., et al. Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb. Mech. Dev. 57 (1996) 145-157
37. El Ghouzzi V., Le Merrer M., Perrin-Schmitt F., Lajeunie E., Benit P., et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 15 (1997) 42-46
38. Enlow D.H. Normal Craniofacial Growth. In: Cohen Jr. M.M., and MacLean R.E. (Eds). "Craniosynostosis Diagnosis Evaluation and Management" (2000), Oxford University Press, New York 35-47
39. Erlebacher A., Filvaroff E.H., Ye J.Q., and Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol. Biol. Cell 9 (1998) 1903-1918
40. Eswarakumar V.P., Horowitz M.C., Locklin R., Morriss-Kay G.M., and Lonai P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl. Acad. Sci. USA 101 (2004) 12555-12560
41. Eswarakumar V.P., Monsonego-Ornan E., Pines M., Antonopoulou I., Morriss-Kay G.M., et al. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129 (2002) 3783-3793
42. Ferreira J.C., Carter S.M., Bernstein P.S., Jabs E.W., Glickstein J.S., et al. Second-trimester molecular prenatal diagnosis of sporadic Apert syndrome following suspicious ultrasound findings. Ultrasound Obstet. Gynecol. 14 (1999) 426-430
43. Filvaroff E., Erlebacher A., Ye J., Gitelman S.E., Lotz J., et al. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126 (1999) 4267-4279
44. Flenniken A.M., Gale N.W., Yancopoulos G.D., and Wilkinson D.G. Distinct and overlapping expression patterns of ligands for Eph-related receptor tyrosine kinases during mouse embryogenesis. Dev. Biol. 179 (1996) 382-401
45. Fong K.D., Song H.M., Nacamuli R.P., Franc B.L., Mari C., et al. Apoptosis in a rodent model of cranial suture fusion: In situ imaging and gene expression analysis. Plast. Reconstr. Surg. 113 (2004) 2037-2047
46. Francis P.H., Richardson M.K., Brickell P.M., and Tickle C. Bone morphogenetic proteins and a signalling pathway that controls patterning in the developing chick limb. Development 120 (1994) 209-218
47. Frolik C.A., Ellis L.F., and Williams D.C. Isolation and characterization of insulin-like growth factor-II from human bone. Biochem. Biophys. Res. Commun. 151 (1988) 1011-1018
48. Furtwangler J.A., Hall S.H., and Koskinen-Moffett L.K. Sutural morphogenesis in the mouse calvaria: The role of apoptosis. Acta Anat. (Basel) 124 (1985) 74-80
49. Gold L.I., Sung J.J., Siebert J.W., and Longaker M.T. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair. Am. J. Pathol. 150 (1997) 209-222
50. Gosain A.K., Recinos R.F., Agresti M., and Khanna A.K. TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures. Plast. Reconstr. Surg. 113 (2004) 1675-1684
51. Greenwald J.A., Mehrara B.J., Spector J.A., Warren S.M., Crisera F.E., et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: Implications for suture fusion and patency. J. Bone Miner. Res. 15 (2000) 2413-2430
52. Greenwald J.A., Mehrara B.J., Spector J.A., Warren S.M., Fagenholz P.J., et al. In vivo modulation of FGF biological activity alters cranial suture fate. Am. J. Pathol. 158 (2001) 441-452
53. Gripp K.W., Zackai E.H., and Stolle C.A. Mutations in the human TWIST gene. Hum. Mutation 15 (2000) 150-155
54. Groppe J., Greenwald J., Wiater E., Rodriguez-Leon J., Economides A.N., et al. Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein. J. Bone Joint Surg. Am. 85-A Suppl. 3 (2003) 52-58
55. Gullaud M., Delanoue R., and Silber J. A Drosophila model to study the functions of TWIST orthologs in apoptosis and proliferation. Cell Death Differ. 10 (2003) 641-651
56. Hajihosseini M.K., Lalioti M.D., Arthaud S., Burgar H.R., Brown J.M., et al. Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131 (2004) 325-335
57. Hobar P.C., Schreiber J.S., McCarthy J.G., and Thomas P.A. The role of the dura in cranial bone regeneration in the immature animal. Plast. Reconstr. Surg. 92 (1993) 405-410
58. Howard T.D., Paznekas W.A., Green E.D., Chiang L.C., Ma N., et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15 (1997) 36-41
59. Hunter A.G., and Rudd N.L. Craniosynostosis. I. Sagittal synostosis: Its genetics and associated clinical findings in 214 patients who lacked involvement of the coronal suture(s). Teratology 14 (1976) 185-193
60. Hunter A.G., and Rudd N.L. Craniosynostosis. II. Coronal synostosis: Its familial characteristics and associated clinical findings in 109 patients lacking bilateral polysyndactyly or syndactyly. Teratology 15 (1977) 301-309
61. Ibrahimi O.A., Eliseenkova A.V., Plotnikov A.N., Yu K., Ornitz D.M., et al. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc. Natl. Acad. Sci. USA 98 (2001) 7182-7187
62. Ibrahimi O.A., Zhang F., Eliseenkova A.V., Linhardt R.J., and Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum. Mol. Genet. 13 (2004) 69-78
63. Iseki S., Wilkie A.O., Heath J.K., Ishimaru T., Eto K., et al. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124 (1997) 3375-3384
64. Iseki S., Wilkie A.O., and Morriss-Kay G.M. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126 (1999) 5611-5620
65. Ishii M., Merrill A.E., Chan Y.S., Gitelman I., Rice D.P., et al. Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 130 (2003) 6131-6142
66. Jabs E.W. A TWIST in the fate of human osteoblasts identifies signaling molecules involved in skull development. J. Clin. Invest. 107 (2001) 1075-1077
67. Jabs E.W., Li X., Scott A.F., Meyers G., Chen W., et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat. Genet. 8 (1994) 275-279
68. Jabs E.W., Muller U., Li X., Ma L., Luo W., et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75 (1993) 443-450
69. Jaye M., Schlessinger J., and Dionne C.A. Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction. Biochim. Biophys. Acta 1135 (1992) 185-199
70. Jiang X., Iseki S., Maxson R.E., Sucov H.M., and Morriss-Kay G.M. Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 241 (2002) 106-116
71. Johnson D., Horsley S.W., Moloney D.M., Oldridge M., Twigg S.R., et al. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am. J. Hum. Genet. 63 (1998) 1282-1293
72. Johnson D., Iseki S., Wilkie A.O., and Morriss-Kay G.M. Expression patterns of Twist and Fgfr1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis. Mech. Dev. 91 (2000) 341-345
73. Johnson D.E., and Williams L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60 (1993) 1-41
74. Kan S.H., Elanko N., Johnson D., Cornejo-Roldan L., Cook J., et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am. J. Hum. Genet. 70 (2002) 472-486
75. Kim H.J., Rice D.P., Kettunen P.J., and Thesleff I. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125 (1998) 1241-1251
76. Kingsley D.M. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8 (1994) 133-146
77. Kingsley D.M., Bland A.E., Grubber J.M., Marker P.C., Russell L.B., et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 71 (1992) 399-410
78. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
79. Lajeunie E., Le Merrer M., Bonaiti-Pellie C., Marchac D., and Renier D. Genetic study of nonsyndromic coronal craniosynostosis. Am. J. Med. Genet. 55 (1995) 500-504
80. Lajeunie E., Le Merrer M., Bonaiti-Pellie C., Marchac D., and Renier D. Genetic study of scaphocephaly. Am. J. Med. Genet. 62 (1996) 282-285
81. Lee M.S., Lowe G.N., Strong D.D., Wergedal J.E., and Glackin C.A. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J. Cell. Biochem. 75 (1999) 566-577
82. Lemonnier J., Hay E., Delannoy P., Fromigue O., Lomri A., et al. Increased osteoblast apoptosis in apert craniosynostosis: Role of protein kinase C and interleukin-1. Am. J. Pathol. 158 (2001) 1833-1842
83. Lenton K.A. Personal communication (2004)
84. Levine J.P., Bradley J.P., Roth D.A., McCarthy J.G., and Longaker M.T. Studies in cranial suture biology: Regional dura mater determines overlying suture biology. Plast. Reconstr. Surg. 101 (1998) 1441-1447
85. Li L., Cserjesi P., and Olson E.N. Dermo-1: A novel twist-related bHLH protein expressed in the developing dermis. Dev. Biol. 172 (1995) 280-292
86. Lin K., Nolen A., Gampper T., Jane J., Opperman L., et al. Elevated levels of transforming growth factors beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly. Cleft Palate Craniofac. J. 34 (1997) 331-337
87. Liu Y.H., Tang Z., Kundu R.K., Wu L., Luo W., et al. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans. Dev. Biol. 205 (1999) 260-274
88. Liu Z., Xu J., Colvin J.S., and Ornitz D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16 (2002) 859-869
89. Ma L., Golden S., Wu L., and Maxson R. The molecular basis of Boston-type craniosynostosis: The Pro148->His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences. Hum. Mol. Genet. 5 (1996) 1915-1920
90. Mabbutt L.W., and Kokich V.G. Calvarial and sutural re-development following craniectomy in the neonatal rabbit. J. Anat. 129 (1979) 413-422
91. Mabbutt L.W., Kokich V.G., Moffett B.C., and Loeser J.D. Subtotal neonatal calvariectomy. A radiographic and histological evaluation of calvarial and sutural redevelopment in rabbits. J. Neurosurg. 51 (1979) 691-696
92. Maestro R., Dei Tos A.P., Hamamori Y., Krasnokutsky S., Sartorelli V., et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13 (1999) 2207-2217
93. Manzanares M.C., Goret-Nicaise M., and Dhem A. Metopic sutural closure in the human skull. J. Anat. 161 (1988) 203-215
94. Massague J., and Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 14 (2000) 627-644
95. Mathijssen I.M., van Leeuwen J.P., and Vermeij-Keers C. Simultaneous induction of apoptosis, collagen type I expression and mineralization in the developing coronal suture following FGF4 and FGF2 application. J. Craniofac. Genet. Dev. Biol. 20 (2000) 127-136
96. McCarthy T.L., Centrella M., and Canalis E. Insulin-like growth factor (IGF) and bone. Connect. Tissue Res. 20 (1989) 277-282
97. McMahon J.A., Takada S., Zimmerman L.B., Fan C.M., Harland R.M., et al. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev. 12 (1998) 1438-1452
98. Mehrara B.J., Greenwald J., Chin G.S., Dudziak M., Sagrioglu J., et al. Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures. Plast. Reconstr. Surg. 104 (1999) 1003-1013
99. Mehrara B.J., Mackool R.J., McCarthy J.G., Gittes G.K., and Longaker M.T. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast. Reconstr. Surg. 102 (1998) 1805-1817
100. Mehrara B.J., Spector J.A., Greenwald J.A., Ueno H., and Longaker M.T. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plast. Reconstr. Surg. 110 (2002) 506-514
101. Mehrara B.J., Steinbrech D.S., Saadeh P.B., Gittes G.K., and Longaker M.T. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann. Plast. Surg. 42 (1999) 502-508
102. Miki T., Bottaro D.P., Fleming T.P., Smith C.L., Burgess W.H., et al. Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. PNAS 89 (1992) 246-250
103. Mooney M.P., Aston C.E., Siegel M.I., Losken H.W., Smith T.D., et al. Craniosynostosis with autosomal dominant transmission in New Zealand white rabbits. J. Craniofac. Genet. Dev. Biol. 16 (1996) 52-63
104. Moore R., Ferretti P., Copp A., and Thorogood P. Blocking endogenous FGF-2 activity prevents cranial osteogenesis. Dev. Biol. 243 (2002) 99-114
105. Morriss-Kay G.M., Iseki S., and Johnson D. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: Roles of fibroblast growth factor receptor signalling pathways. Novartis Found. Symp. 232 (2001) 102-116
106. Moss M.L. Fusion of the frontal suture in the rat. Am. J. Anat. 102 (1958) 141-165
107. Moss M.L. The pathogenesis of premature cranial synostosis in man. Acta Anat. (Basel) 37 (1959) 351-370
108. Moss M.L. Inhibition and stimulation of sutural fusion in the rat calvaria. Anat. Rec. 136 (1960) 457-467
109. Mossaz C., and Kokich V.G. Redevelopment of the calvaria after partial craniectomy in growing rabbits: The effect of altering dural continuity. Acta. Anat. 109 (1981) 321-331
110. Most D., Levine J.P., Chang J., Sung J., McCarthy J.G., et al. Studies in cranial suture biology: Up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast. Reconstr. Surg. 101 (1998) 1431-1440
111. Moursi A.M., Winnard P.L., Fryer D., and Mooney M.P. Delivery of transforming growth factor-beta2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture. Cleft Palate Craniofac. J. 40 (2003) 225-232
112. Muenke M., Gripp K.W., McDonald-McGinn D.M., Gaudenz K., Whitaker L.A., et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet. 60 (1997) 555-564
113. Muenke M., Schell U., Hehr A., Robin N.H., Losken H.W., et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8 (1994) 269-274
114. Muller U., Warman M.L., Mulliken J.B., and Weber J.L. Assignment of a gene locus involved in craniosynostosis to chromosome 5qter. Hum. Mol. Genet. 2 (1993) 119-122
115. Murray S.S., Glackin C.A., Winters K.A., Gazit D., Kahn A.J., et al. Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J. Bone Miner. Res. 7 (1992) 1131-1138
116. Nacamuli R.P., Fong K.D., Lenton K.A., Song H.M., Fang T.D., et al. Expression and possible mechanisms of regulation of BMP3 in rat cranial sutures. Plas. Reconst. Surg. (2004) (manuscript submitted)
117. Nacamuli R.P., Song H.M., Fang T.D., Fong K.D., Mathy J.A., et al. Quantitative transcriptional analysis of fusing and non-fusing cranial suture complexes in mice. Plast. Reconstr. Surg. 114 (2004) 1818-1825
118. Nappen D.L., and Kokich V.G. Experimental craniosynostosis in growing rabbits. The role of the periosteum. J. Neurosurg. 58 (1983) 101-108
119. Naski M.C., and Ornitz D.M. FGF signaling in skeletal development. Front. Biosci. 3 (1998) 781-794
120. Noden D.M. The control of avian cephalic neural crest cytodifferentiation. I. Skeletal and connective tissues. Dev. Biol. 67 (1978) 296-312
121. Noden D.M. Interactions and fates of avian craniofacial mesenchyme. Development 103 (1988) 121-140
122. Northrop J., Woods A., Seger R., Suzuki A., Ueno N., et al. BMP-4 regulates the dorsal-ventral differences in FGF{plus 45 degree rule}MAPKK-mediated mesoderm induction in Xenopus. Dev. Biol. 172 (1995) 242-252
123. Nusslein-Volhard C., Wieschaus E., and Kluding H. Mutations affecting the pattern of the larval cuticle in Drosophila melanogaster. Zygotic loci on the second chromosome. Wilhelm Roux's Arch. Dev. Biol. 193 (1984) 267-282
124. Ohbayashi N., Shibayama M., Kurotaki Y., Imanishi M., Fujimori T., et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16 (2002) 870-879
125. Oldridge M., Wilkie A.O., Slaney S.F., Poole M.D., Pulleyn L.J., et al. Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum. Mol. Genet. 4 (1995) 1077-1082
126. Opperman L.A. Cranial sutures as intramembranous bone growth sites. Dev. Dyn. 219 (2000) 472-485
127. Opperman L.A., Adab K., and Gakunga P.T. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev. Dyn. 219 (2000) 237-247
128. Opperman L.A., Chhabra A., Cho R.W., and Ogle R.C. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J. Craniofac. Genet. Dev. Biol. 19 (1999) 164-173
129. Opperman L.A., Galanis V., Williams A.R., and Adab K. Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration. Orthod. Craniofac. Res. 5 (2002) 5-16
130. Opperman L.A., Nolen A.A., and Ogle R.C. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J. Bone Miner. Res. 12 (1997) 301-310
131. Opperman L.A., Passarelli R.W., Morgan E.P., Reintjes M., and Ogle R.C. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J. Bone Miner. Res. 10 (1995) 1978-1987
132. Opperman L.A., Passarelli R.W., Nolen A.A., Gampper T.J., Lin K.Y.K., et al. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev. Biol. Animal 32 (1996) 627-632
133. Opperman L.A., Persing J.A., Sheen R., and Ogle R.C. In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration. J. Craniofac. Surg. 5 (1994) 327-332
134. Opperman L.A., Sweeney T.M., Redmon J., Persing J.A., and Ogle R.C. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dyn. 198 (1993) 312-322
135. Ornitz D.M., and Itoh N. Fibroblast growth factors. Genome Biol 2 (2001) REVIEWS 3005.1-REVIEWS 3005.12
136. Ornitz D.M., and Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16 (2002) 1446-1465
137. O'Rourke M.P., and Tam P.P. Twist functions in mouse development. Int. J. Dev. Biol. 46 (2002) 401-413
138. Orr-Urtreger A., Bedford M.T., Burakova T., Arman E., Zimmer Y., et al. Developmental localization of the splicing alternatives of Fibroblast Growth Factor Receptor-2 (FGFR2). Dev. Biol. 158 (1993) 475-486
139. Otto A.W. Lehrbuch der Pathologischen Anatomie (1830), Rücher, Berlin, Germany
140. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
141. Pajer P., Pecenka V., Karafiat V., Kralova J., Horejsi Z., et al. The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma. Oncogene 22 (2003) 665-673
142. Park E.A., and Powers G.F. Acrocephaly and scaphocephaly with symmetrically distributed malformations of the extremities. Am. J. Dis. Child 20 (1920) 235-315
143. Park W.J., Meyers G.A., Li X., Theda C., Day D., et al. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum. Mol. Genet. 4 (1995) 1229-1233
144. Paznekas W.A., Cunningham M.L., Howard T.D., Korf B.R., Lipson M.H., et al. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am. J. Hum. Genet. 62 (1998) 1370-1380
145. Posnick J.C. Craniofacial syndromes and anomalies. In: Posnick J.C. (Ed). "Craniofacial and Maxillofacial Surgery in Children and Young Adults" Vol. 1 (2000), W. B. Saunders, Philadelphia 391-527
146. Powers C.J., McLeskey S.W., and Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7 (2000) 165-197
147. Reardon W., and Winter R.M. Saethre-Chotzen syndrome. J. Med. Genet. 31 (1994) 393-396
148. Rice D.P., Aberg T., Chan Y., Tang Z., Kettunen P.J., et al. Integration of FGF and TWIST in calvarial bone and suture development. Development 127 (2000) 1845-1855
149. Rice D.P., Kim H.J., and Thesleff I. Apoptosis in murine calvarial bone and suture development. Eur. J. Oral Sci. 107 (1999) 265-275
150. Richtsmeier J.T., Baxter L.L., and Reeves R.H. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev. Dyn. 217 (2000) 137-145
151. Robin N.H., Feldman G.J., Mitchell H.F., Lorenz P., Wilroy R.S., et al. Linkage of Pfeiffer syndrome to chromosome 8 centromere and evidence for genetic heterogeneity. Hum. Mol. Genet. 3 (1994) 2153-2158
152. Roth D.A., Bradley J.P., Levine J.P., McMullen H.F., McCarthy J.G., et al. Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast. Reconstr. Surg. 97 (1996) 693-699
153. Roth D.A., Gold L.I., Han V.K., McCarthy J.G., Sung J.J., et al. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast. Reconstr. Surg. 99 (1997) 300-309
154. Roth D.A., Gold L.I., Han V.K., McCarthy J.G., Sung J.J., et al. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast. Reconstr. Surg. 99 (1997) 300-309 discussion 310-306
155. Sagiroglu J.S., Mehrara B.J., Chau D., Saadeh P.B., Gittes G.K., et al. Analysis of TGF-beta production by fusing and nonfusing mouse cranial sutures in vitro. Ann. Plast. Surg. 42 (1999) 496-501
156. Sarkar S., Petiot A., Copp A., Ferretti P., and Thorogood P. FGF2 promotes skeletogenic differentiation of cranial neural crest cells. Development 128 (2001) 2143-2152
157. Satokata I., Ma L., Ohshima H., Bei M., Woo I., et al. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 24 (2000) 391-395
158. Schneider R.A., Hu D., and Helms J.A. From head to toe: Conservation of molecular signals regulating limb and craniofacial morphogenesis. Cell Tissue Res. 296 (1999) 103-109
159. Shishido E., Higashijima S., Emori Y., and Saigo K. Two FGF-receptor homologues of Drosophila: One is expressed in mesodermal primordium in early embryos. Development 117 (1993) 751-761
160. Smith W.C., and Harland R.M. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70 (1992) 829-840
161. Song H.M., Fong K.D., Nacamuli R.P., Warren S.M., Fang T.D., et al. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus. Plast. Reconstr. Surg. 113 (2004) 1685-1697
162. Song H.M., Nacamuli R.P., Xia W., Bari A.S., Shi Y.-Y., et al. High-dose retinoic acid modulates rat calvarial osteoblast biology. J. Cell Phys. 202 (2005) 255-262
163. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21 (1999) 70-71
164. Spector J.A., Greenwald J.A., Warren S.M., Bouletreau P.J., Crisera F.E., et al. Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation. Plast. Reconstr. Surg. 109 (2002) 631-642
165. Spector J.A., Mehrara B.J., Greenwald J.A., Saadeh P.B., Steinbrech D.S., et al. A molecular analysis of the isolated rat posterior frontal and sagittal sutures: Differences in gene expression. Plast. Reconstr. Surg. 106 (2000) 852-861
166. Stelnicki E.J., Vanderwall K., Hoffman W.Y., Harrison M.R., Glowacki J., et al. A new in utero sheep model for unilateral coronal craniosynostosis. Plast. Reconstr. Surg. 101 (1998) 278-286
167. Takao M., Hino J., Takeshita N., Konno Y., Nishizawa T., et al. Identification of rat bone morphogenetic protein-3b (BMP-3b), a new member of BMP-3. Biochem. Biophys. Res. Commun. 219 (1996) 656-662
168. Tang X.X., Biegel J.A., Nycum L.M., Yoshioka A., Brodeur G.M., et al. cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain. Genomics 29 (1995) 426-437
169. Tavormina P.L., Shiang R., Thompson L.M., Zhu Y.Z., Wilkin D.J., et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9 (1995) 321-328
170. Tessier P. [Total facial osteotomy. Crouzon's syndrome, Apert's syndrome: Oxycephaly, scaphocephaly, turricephaly]. Ann. Chir. Plast. 12 (1967) 273-286
171. Tessier P. [The treatment of facial dysmorphy peculiary to cranio-facial dysostosis (C.F.D.). Crouzon and Apert diseases. Total osteotomy and sagittal displacement of the facial mass]. Chirurgie 96 (1970) 667-674
172. Thomas J.A., Manchester D.K., Prescott K.E., Milner R., McGavran L., et al. Hunter-McAlpine craniosynostosis phenotype associated with skeletal anomalies and interstitial deletion of chromosome 17q. Am. J. Med. Genet. 62 (1996) 372-375
173. Ting K., Vastardis H., Mulliken J.B., Soo C., Tieu A., et al. Human NELL-1 expressed in unilateral coronal synostosis. J. Bone Miner. Res. 14 (1999) 80-89
174. Twigg S.R., Kan R., Babbs C., Bochukova E.G., Robertson S.P., et al. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc. Natl. Acad. Sci. USA 101 (2004) 8652-8657
175. Virchow R. Ueber den Cretinismus, namentlich in Franken, und ueber pathologische Schaedelformen. Verh. Phys. Med. Gesellsch. Wuerzburg 2 (1851) 231-271
176. von Gernet S., Golla A., Ehrenfels Y., Schuffenhauer S., and Fairley J.D. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. Clin. Genet. 57 (2000) 137-139
177. Wang J.S. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop. Scand. Supp. 269 (1996) 1-27
178. Warman M.L., Mulliken J.B., Hayward P.G., and Muller U. Newly recognized autosomal dominant disorder with craniosynostosis. Am. J. Med. Genet. 46 (1993) 444-449
179. Warren S.M., Brunet L.J., Harland R.M., Economides A.N., and Longaker M.T. The BMP antagonist noggin regulates cranial suture fusion. Nature 422 (2003) 625-629
180. Warren S.M., Greenwald J.A., Nacamuli R.P., Fong K.D., Song H.J., et al. Regional dura mater differentially regulates osteoblast gene expression. J. Craniofac. Surg. 14 (2003) 363-370
181. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420 (2002) 520-562
182. Weinzweig J., Kirschner R.E., Farley A., Reiss P., Hunter J., et al. Metopic synostosis: Defining the temporal sequence of normal suture fusion and differentiating it from synostosis on the basis of computed tomography images. Plast. Reconstr. Surg. 112 (2003) 1211-1218
183. Wieland I., Jakubiczka S., Muschke P., Cohen M., Thiele H., et al. Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am. J. Hum. Genet. 74 (2004) 1209-1215
184. Wilkie A.O. Craniosynostosis: Genes and mechanisms. Hum. Mol. Genet. 6 (1997) 1647-1656
185. Wilkie A.O., and Morriss-Kay G.M. Genetics of craniofacial development and malformation. Nat. Rev. Genet. 2 (2001) 458-468
186. Wilkie A.O., Oldridge M., Tang Z., and Maxson Jr. R.E. Craniosynostosis and related limb anomalies. Novartis Found. Symp. 232 (2001) 122-133
187. Wilkie A.O.M., Morriss-Kay G.M., Jones E.Y., and Heath J.K. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5 (1995) 500-507
188. Wilkie A.O.M., Slaney S.F., Oldridge M., Poole M.D., Ashworth J.G., et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9 (1995) 165-171
189. Wilkie A.O.M., Tang Z., Elanko N., Walsh S., Twigg S.R., et al. Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nat. Genet. 24 (2000) 387-390
190. Winograd J., Reilly M.P., Roe R., Lutz J., Laughner E., et al. Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice. Hum. Mol. Genet. 6 (1997) 369-379
191. Wolf C., Thisse C., Stoetzel C., Thisse B., Gerlinger P., et al. The M-twist gene of Mus is expressed in subsets of mesodermal cells and is closely related to the Xenopus X-twi and the Drosophila twist genes. Dev. Biol. 143 (1991) 363-373
192. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., et al. Novel regulators of bone formation: Molecular clones and activities. Science 242 (1988) 1528-1534
193. Yu J.C., McClintock J.S., Gannon F., Gao X.X., Mobasser J.P., et al. Regional differences of dura osteoinduction: Squamous dura induces osteogenesis, sutural dura induces chondrogenesis, and osteogenesis. Plast. Reconstr. Surg. 100 (1997) 23-31
194. Yu K., Xu J., Liu Z., Sosic D., Shao J., et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130 (2003) 3063-3074
195. Zhang X., Carpenter D., Bokui N., Soo C., Miao S., et al. Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development. J. Bone Miner. Res. 18 (2003) 2126-2134
196. Zhang X., Kuroda S., Carpenter D., Nishimura I., Soo C., et al. Craniosynostosis in transgenic mice overexpressing Nell-1. J. Clin. Invest 110 (2002) 861-870
197. Zhou Y.X., Xu X., Chen L., Li C., Brodie S.G., et al. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum. Mol. Genet. 9 (2000) 2001-2008
198. Zimmerman L.B., De Jesús-Escobar J.M., and Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86 (1996) 599-606